Commerce Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-801
| Closed | -$263K | – | 1179 |
|
|
2024
Q4 | $263K | Buy |
801
+84
| +12% | +$27.6K | ﹤0.01% | 1063 |
|
|
2024
Q3 | $240K | Buy |
+717
| New | +$240K | ﹤0.01% | 1124 |
|
|
2024
Q2 | – | Sell |
-746
| Closed | -$258K | – | 1198 |
|
|
2024
Q1 | $258K | Buy |
746
+51
| +7% | +$17.6K | ﹤0.01% | 1074 |
|
|
2023
Q4 | $224K | Sell |
695
-55
| -7% | -$17.8K | ﹤0.01% | 1104 |
|
|
2023
Q3 | $269K | Sell |
750
-8
| -1% | -$2.87K | ﹤0.01% | 989 |
|
|
2023
Q2 | $287K | Buy |
758
+148
| +24% | +$56.1K | ﹤0.01% | 982 |
|
|
2023
Q1 | $292K | Sell |
610
-429
| -41% | -$205K | ﹤0.01% | 991 |
|
|
2022
Q4 | $437K | Sell |
1,039
-2
| -0.2% | -$841 | ﹤0.01% | 842 |
|
|
2022
Q3 | $435K | Sell |
1,041
-223
| -18% | -$93.2K | ﹤0.01% | 816 |
|
|
2022
Q2 | $625K | Buy |
1,264
+403
| +47% | +$199K | 0.01% | 685 |
|
|
2022
Q1 | $485K | Sell |
861
-60
| -7% | -$33.8K | ﹤0.01% | 843 |
|
|
2021
Q4 | $696K | Sell |
921
-16
| -2% | -$12.1K | ﹤0.01% | 732 |
|
|
2021
Q3 | $699K | Buy |
937
+252
| +37% | +$188K | ﹤0.01% | 718 |
|
|
2021
Q2 | $441K | Buy |
685
+21
| +3% | +$13.5K | ﹤0.01% | 877 |
|
|
2021
Q1 | $379K | Sell |
664
-114
| -15% | -$65.1K | ﹤0.01% | 901 |
|
|
2020
Q4 | $454K | Sell |
778
-83
| -10% | -$48.4K | ﹤0.01% | 809 |
|
|
2020
Q3 | $444K | Buy |
861
+178
| +26% | +$91.8K | ﹤0.01% | 723 |
|
|
2020
Q2 | $308K | Sell |
683
-843
| -55% | -$380K | ﹤0.01% | 832 |
|
|
2020
Q1 | $535K | Buy |
1,526
+516
| +51% | +$181K | 0.01% | 565 |
|
|
2019
Q4 | $374K | Sell |
1,010
-12
| -1% | -$4.44K | ﹤0.01% | 743 |
|
|
2019
Q3 | $340K | Buy |
1,022
+149
| +17% | +$49.6K | ﹤0.01% | 736 |
|
|
2019
Q2 | $273K | Buy |
873
+58
| +7% | +$18.1K | ﹤0.01% | 794 |
|
|
2019
Q1 | $249K | Buy |
+815
| New | +$249K | ﹤0.01% | 779 |
|